BIT’s 7th Annual World Congress of Regenerative Medicine & Stem Cells-2014

BIT’s 7^th Annual World Congress of Regenerative Medicine & Stem Cells-2014

 

Theme: Translation from Concepts to Market

Time: November 13-16, 2014
Venue: Haikou,China

 

http://www.bitlifesciences.com/rmsc2014/

 

Dear Friends and Colleagues,

On behalf of the Organizing Committee of BIT’s 7^th Annual World Congress of Regenerative Medicine & Stem Cell (RMSC-2014), it is a great honor to welcome you from all over the world.

Nearly 200 participants from more than 30 countries and areas have attended the meeting last year. Everyone has deeply enjoyed the unforgettable gathering in Dalian. Here I am honored to declare RMSC-2014 will be held in Haikou, China during Nov. 13-16, 2014. This event focuses on building a bridge between researchers, investors and manufacturers in the field of Regenerative Medicine & Stem Cell. The aim of RMSC-2014 is to promote the development of Regenerative Medicine & Stem Cell.

Regenerative medicine and stem cell are currently hot subjects of research in today’s life sciences and have provided many optional treatment of some diseases such as cancer, nervous disease, damaged organs and degenerative diseases, etc. RMSC-2014 will provide all participants with resources, information and advice they need to support their research, decision making and future professional developments.

I appreciate many individuals and organizations that have worked so hard to make RMSC-2014 a successful conference.

Finally, thanks to the participants of this conference! Wish you enjoy the conference.

Sincerely Yours,

 

Yours,

Dr. Xiaodan Mei

Executive Chair of RMSC-2014

Conference Highlights:

• 44 Distinguished Sections Cover Current Hot Topics and Issues in Regenerative Medicine & Stem Cell
• 30+ Exhibitors Showing Innovative Advanced Products and Technology
• 150+ Oral Presentations from Authority, Governmental Decision Makers, Distinguished Scientists, Engineers, Industrial Executives and Investors
• 200+ Participants from Active Groups and Parties in the Related Field
• Opportunity to Have an Amazing and Wonderful Tour to Chinese Landscape

Plenary	Sector 1	Sector 2				Sector 3
	Session P	Forum 1	Forum 2	Forum 3	Forum 4	Symposium 1	Symposium 2	Symposium 3

Event Title: Session P1: Legal, Politics, Ethic, Safety Issues and Social Acceptance of Stem Cell Research
Day 2: Morning, Friday, November 14, 2014 08:30-12:10 Place: Hainan International Convention & Exhibition Center, Haikou, China
Chair: Mr. David C. Oxley, Senior Vice President, Emerging Markets & General Manager, Cytori Therapeutics, Inc., USA Co-Chair: Dr. Tomoyuki Takura, Professor, Osaka University Graduate School of Medicine, Japan
Time	Speeches and Speakers
07:00-08:00	Registration & Continental Breakfast Network
08:55-09:20	Title: Fresh, Autologous Adipose Derived Regenerative Cells in Medicine: A 7000 Patient Clinical Review Speaker: David C. Oxley, Senior Vice President, Emerging Markets & General Manager, Cytori Therapeutics, Inc., USA
09:20-09:45	Title: The Impact on the Mankind and Human Society in General if the Stem Cell Therapy Fulfilled Its Promise Speaker: Dr. Malik M. Hasan, Founder and CEO, HealthTrio, USA
09:45-10:10	Title: Ethical Challenges in Regenerative Medicine - Hopes and Fears - in the Opinion of Polish Society Speaker: Dr. Alicja Laska-Formejster, Sociologist, University of Lodz, Poland
10:10-10:30	Coffee Break
10:30-10:55	Title: Socioeconomic Impact of Regenerative Medicine in Medical Insurance System Speaker: Dr. Tomoyuki Takura, Professor, Osaka University Graduate School of Medicine, Japan
10:55-11:20	Title: Implications of Legal Decisions on Stem Cell Research: International Comparative Perspectives Speaker: Bianca Buechner, Associated Research Fellow, Leibniz Universität Hannover, Germany
11:20-11:45	Title: Ethical and Legal Issues on Stem Cell Research in South Korea Speaker:Dr. So Yoon Kim, Staffs, Yonsei University College of Medicine, South Korea
11:45-12:10	Title: Regenerative Policies Speaker: Dr. Judit Sandor, Professor, Central European University, Hungary
12:00-13:30	Lunch Showcase

Event Title: Session P2: Milestones in Stem Cell and Tissue Engineering Research
Day 2: Morning, Friday, November 14, 2014 08:30-12:10 Place: Hainan International Convention & Exhibition Center, Haikou, China
Chair: Dr. Xuetao Pei, Director & Professor, Beijing Institute of Transfusion Medicine, China Co-Chair: Dr. Say-June Kim, Associate Professor,Catholic University of Korea, South Korea
Time	Speeches and Speakers
07:00-08:00	Registration & Continental Breakfast Network
08:30-08:55	Title: New Small-Molecule for Mobilizing Marrow Stem Cells Speaker: Dr. Xuetao Pei, Director & Professor, Beijing Institute of Transfusion Medicine, China
08:55-09:20	Title: Under Preparation Speaker: Dr. Paul August, Director, US Head of Early to Candidate Unit, Sanofi-Aventis, USA
09:20-09:45	Title: Stem Cells Are the Future of Medicinem Speaker: Dr. Eckhard U. Alt, Professor, The University of Texas M. D. Anderson Cancer Center; Tulane University Health Science Center, USA
09:45-10:10	Title: Under Preparation Speaker: Dr. Y. James Kang, Professor, University of Louisville, USA; Director, Sichuan University, China
10:10-10:30	Coffee Break
10:30-10:55	Title: A Novel Cell-Free Strategies to Use Secretome as an Advantageous Alternative to Stem Cells Speaker: Dr. Say-June Kim, Associate Professor,Catholic University of Korea, South Korea
10:55-11:20	Title: Long-term Culture and Identification of the Spermatogonial Stem Cells from the Testes of Cynomolgus Monkey Speaker: Dr. Yingji Wu, Professor, Hainan Provincial People’s Hospital, China
11:20-11:45	Title: Application of Microforming to Create Chondrocyte Home Sites in a Natural Cartilage Matrix Speaker: Dr. Thomas P. James, Associate Professor, Tufts University, USA
11:45-12:10	Title: Pokrovski Stem Cells Bank Activities on the Procurement of Biomaterial for Regenerative Medicine Speaker: Dr. Dmitry Ivolgin, Medical Director, Pokrovski Stem Cell Bank, Russia
12:00-13:30	Lunch Showcase

Event Title: Session P3: Outlook for Global Market Trend and Business Development
Day 3: Morning, Saturday, November 15, 2014 08:30-12:10 Place: Hainan International Convention & Exhibition Center, Haikou, China
Chair: Dr. Stefanos Theoharis, Chief Business Officer, Apceth GmbH & Co KG, Germany Co-Chair: Dr. Barley Yan, New Business Development Manager,  Life Technologies, China
Time	Speeches and Speakers
07:00-08:00	Registration & Continental Breakfast Network
08:55-09:20	Title: Market Trends, Business Development and Evolution of Cell Therapies Speaker: Dr. Stefanos Theoharis, Chief Business Officer, Apceth GmbH & Co KG, Germany
09:20-09:45	Title: Only an Economist Would Define: A Longer Healthy Life, As a Disaster Speaker: Dr. Rick Blume, Managing Director, Excel Venture Management, USA
09:45-10:10	Title: The Current Landscape for Commercializing Adult Stem Cells in Regenerative Medicine Speaker: Dr. John F. Wong, Chairman & Chief Executive Officer, Moraga Biotechnology Corporation, USA
10:10-10:30	Coffee Break
10:30-10:55	Title: Advancements in Culturing and Reprogramming of Human Pluripotent Stem Cells Speaker: Dr. Barley Yan, New Business Development Manager, Life Technologies, China
10:55-11:20	Title: Paradigms in Healthcare --Could the Stem Cell Space Be Next? Speaker: Mr. Jason Kolbert, Managing Director of Biotechnology Research, Maxim Group, USA
11:20-11:45	Title: Stem Cell Research- The India Perspective Speaker: Mr. Debolina Partap, Associate Vice President and Head Legal, Wockhardt, India
12:00-13:30	Lunch Showcase

Event Title: Session P4: Stem Cell and Tissue Engineering Product Development
Day 3: Morning, Saturday, November 15, 2014 08:30-12:10 Place: Hainan International Convention & Exhibition Center, Haikou, China
Chair: Dr. William Cao, CEO, Cellular Biomedicine Group Inc., USA Co-Chair: Dr. Mitchell Seyedin, Executive Chairman, ISTO Technologies, Inc., USA
Time	Speeches and Speakers
07:00-08:00	Registration & Continental Breakfast Network
08:30-08:55	Title: Challenges and Opportunities in Stem Cell Therapies and Tissue Regeneration Speaker: Mr. Sotirios Karathanasis, Executive Director Strategy, AstraZeneca, USA
09:20-09:45	Title: Preclinical and Clinical Results of Mesenchymal Progenitor Cell Treatment for Osteoarthritis Speaker: Dr. William Cao, CEO, Cellular Biomedicine Group Inc., USA
09:45-10:10	Title: The Development of Systems Therapeutics Using Stem Cell-Based S2rm Technology Speaker: Dr. Greg Maguire, CEO, Co-Founder, BioRegenerative Sciences, Inc., USA
10:10-10:30	Coffee Break
10:30-10:55	Title: Platform Technologies for Bone and Cartilage Regeneration Speaker: Dr. Mitchell Seyedin, Executive Chairman, ISTO Technologies, Inc., USA
10:55-11:20	Title: Tissue Engineering and Regenerative Medicine Accelerating Translation to Patients: Stem Cell Therapies Speaker: Dr. Aisha Khan, Director, University of Miami, USA
11:20-11:45	Title: Human Tissue Based Bioimplant Product Development Speaker: Dr. Silvia Chen, Scientific Officer, LifeNet Health, USA
12:00-13:30	Lunch Showcase

Contact

Allison Wong

BIT Congress Inc.

Dalian Ascendas IT Park

No. 1, Hui Xian Yuan, Dalian

Hi-tech Industrial Zone, LN 116025, P.R.China             

E: allison@bitlifesciences.com   

T: 0086 411 84799609-827 

W: www.bitlifesciences.com